Literature DB >> 16368366

Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect.

Joerg S Sachweh1, Sabine H Daebritz, Benita Hermanns, Bernd Fausten, Stefan Jockenhoevel, Stefan Handt, Bruno J Messmer.   

Abstract

BACKGROUND: The development of hypertensive pulmonary vascular disease (HPVD) is considered a risk factor in the long-term course of patients with secundum atrial septal defects (ASD). The aim of this study was to assess the prevalence and histologic degree of HPVD and pulmonary hypertension in relation to preoperative clinical and hemodynamic data, intraoperative findings, and operative outcome in adults.
METHODS: Lung biopsies of 75 patients, mean age 44 +/- 14 years (18-71 years), with secundum ASD or sinus venosus defect including ten patients with partial anomalous pulmonary venous return were analyzed in accordance with preoperative and intraoperative findings as well as operative outcome. Lung biopsy was performed at the time of defect closure and was classified according to Heath and Edwards.
RESULTS: Structural changes of the pulmonary vasculature were found in 59% of patients; grade 3 and higher changes were present in 19%. There were no statistically significant relations between histologic findings and preoperative clinical and hemodynamic data, intraoperative findings, and operative outcome. The prevalence of moderate (32-50 mm Hg) and severe (> 50 mm Hg) systolic pulmonary hypertension was 27% and 17%, respectively. Increased systolic pulmonary arterial pressure was associated with increased pulmonary vascular resistance (p < 0.000) and patients' age (p = 0.001). Patients with a lower functional capacity had a higher prevalence of pulmonary hypertension (p = 0.011).
CONCLUSIONS: The prevalence of HPVD and pulmonary hypertension in adult patients with secundum ASD or sinus venosus defect is considerable. Preoperative hemodynamic data do not predict the degree of HPVD in lung biopsy. Closure is generally advised to prevent increasing pulmonary arterial pressure and decreasing functional capacity over time.

Entities:  

Mesh:

Year:  2006        PMID: 16368366     DOI: 10.1016/j.athoracsur.2005.07.053

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Rapid Improvement of Pulmonary Functions in Children After Transcatheter Closure of an Atrial Septal Defect.

Authors:  Serkan F Çelik; Cemşit Karakurt; Nurdan Yıldırım Acar; Elif Çelik
Journal:  Pediatr Cardiol       Date:  2017-10-31       Impact factor: 1.655

2.  Benefit of atrial septal defect closure in adults: impact of age.

Authors:  Michael Humenberger; Raphael Rosenhek; Harald Gabriel; Florian Rader; Maria Heger; Ursula Klaar; Thomas Binder; Peter Probst; Georg Heinze; Gerald Maurer; Helmut Baumgartner
Journal:  Eur Heart J       Date:  2010-10-12       Impact factor: 29.983

3.  Improvement of tricuspid regurgitation after transcatheter ASD closure in older patients.

Authors:  L Chen; J Shen; X Shan; F Wang; T Kan; X Tang; X Zhao; Y Qin
Journal:  Herz       Date:  2017-07-19       Impact factor: 1.443

4.  Partial anomalous pulmonary venous drainage in young pediatric patients: the role of magnetic resonance imaging.

Authors:  Eugénie Marie-Christine Riesenkampff; Boris Schmitt; Bernhard Schnackenburg; Michael Huebler; Vladimir Alexi-Meskishvili; Roland Hetzer; Felix Berger; Titus Kuehne
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

Review 5.  Pregnancy in adults with repaired/unrepaired atrial septal defect.

Authors:  Charlène Bredy; François-Pierre Mongeon; Line Leduc; Annie Dore; Paul Khairy
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 6.  Pathophysiology and natural history of atrial septal defect.

Authors:  Laurianne Le Gloan; Antoine Legendre; Laurence Iserin; Magalie Ladouceur
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

7.  Pulmonary blood flow and pulmonary hypertension: Is the pulmonary circulation flowophobic or flowophilic?

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

8.  Transient use of oral bosentan can be an additional option to reduce pulmonary arterial hypertension in a patient with severe pulmonary arterial hypertension associated with atrial septal defect.

Authors:  Yong Kyu Park; Jae-Hyeong Park; Jae Hyeon Yu; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  J Cardiovasc Ultrasound       Date:  2011-09-30

9.  Atrial septal defect repair; our early and mid-phase results.

Authors:  Sedat Ozcan; Ali Umit Yener; M Turgut Alper Ozkan
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

10.  Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports : strategy for ASD with severe PAH.

Authors:  Yu Taniguchi; Noriaki Emoto; Kazuya Miyagawa; Kazuhiko Nakayama; Hiroto Kinutani; Hidekazu Tanaka; Toshiro Shinke; Kenji Okada; Yutaka Okita; Ken-ich Hirata
Journal:  Heart Vessels       Date:  2013-04-18       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.